Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-31 @ 5:21 AM
Study NCT ID:
NCT07414394
Status:
RECRUITING
Last Update Posted:
2026-03-25
First Post:
2026-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tigulixostat (IBI128) vs Febuxostat in Gout
Sponsor:
Innovent Biologics Technology Limited (Shanghai R&D Center)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CIBI128A301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None